Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > LATEST
LATEST
-
ARCHIVE NDA Review Process Needs Further Improvement: New PMSB Director General
February 5, 2001
-
ARCHIVE Tsuruha to Enter Central Tokyo Market
February 5, 2001
-
ARCHIVE Council on Drugs and Food Sanitation Holds First Meeting
February 5, 2001
-
ARCHIVE Kobayashi Pharm Acquires Whitehall Japan Corp.
February 5, 2001
-
ARCHIVE JMA, Kemporen Leaders Agree on Need to Exchange Opinions in April
February 5, 2001
-
ARCHIVE OTC NEWS IN BRIES
February 5, 2001
-
ARCHIVE REGULATORY NEWS IN BRIEF
February 5, 2001
-
ARCHIVE GE-Yokogawa Medical Systems Focuses on Cardiovascular Devices
February 5, 2001
-
ARCHIVE More Than 80% of Clinics Selected Fixed Sum Copayment: PJ Survey
February 5, 2001
-
ARCHIVE Boston Scientific Japan: New Balloon Catheters for PTCA
February 5, 2001
-
ARCHIVE 80.7% of Clinics Select Fixed Sum Copayment
February 5, 2001
-
ARCHIVE MEDICAL DEVICE NEWS IN BRIEF
February 5, 2001
-
ARCHIVE Council to Study Ways to Supply Drug Information to Public
January 29, 2001
-
ARCHIVE Jovi to Increase Its Member Stores to 3,000
January 29, 2001
-
ARCHIVE REGULATORY NEWS IN BRIEF
January 29, 2001
-
ARCHIVE JIRA Aims at Introducing Medical Devices Law
January 29, 2001
-
ARCHIVE Clinical Trial Support System Established in 5 Nat'l Univ.
January 29, 2001
-
ARCHIVE Olympus Aims at \100 Bil. Sales with Genomic Healthcare
January 29, 2001
-
ARCHIVE In vitro Fertilization Using Sperm, Ova from Third Parties to Be Approved
January 29, 2001
-
ARCHIVE Economy, Trade, Industry Ministry to Help Handicapped Persons Obtain Access to Internet
January 29, 2001
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…